| |
|
|
Turmeric
By Dr John
Anne
Turmeric is the
root (or rhizome) of the Asian plant, Curcuma longa or C.
domestica (red valerian, haldi, jiang
huang). When the roots are ground up,
they yield a yellowish powder that resembles saffron; it
is sometimes referred to as Indian saffron. Turmeric is
used as a curry component and as a spice in Indian
cooking, and can be used as a dye. Turmeric and its major
component, curcumin, are both used as
phytomedicines.
Turmeric powder used in
Indian cooking, by Sanjay Acharya
Sanjay. |
Uses and Benefits:
Turmeric has been traditionally
recognized in India as a flavorful, colorful condiment, and as
an Ayurvedic medicine to improve appetite, act as a
carminative, and treat gallstones and other biliary problems,
as well as dyspepsia. It is a traditional remedy in India,
China, and other Southeast Asian countries to treat asthma and
colds, and is applied as an ointment, paste, or poultice for
scabies, boils, bruises, insect bites, and other skin lesions.
Turmeric is given orally for many other conditions, including
menstrual problems, pain, epilepsy, respiratory tract
infections, bleeding, diarrhea, jaundice, and rheumatic
disorders. More recently, it has gained a reputation as an
anti-inflammatory agent, a treatment for hypercholesterolemia,
an antioxidant, and a cancer preventative, and is claimed to
prevent cardiovascular and other degenerative changes of aging.
Claims also are made for its value in allergy, AIDS, cataracts,
and other diseases. Curcumin is added to foods such as butter
and margarine to prevent oxidation and to improve the
color.
Pharmacology:More than 100 components have been isolated
from turmeric. The main medical component of the root is a
volatile oil, containing turmerone, and other coloring agents,
called curcuminoids. Curcumin (diferuloylmethane) is the major
constituent, usually found in a concentration of < 6%.5
Turmeric :;hares some compounds, such as zingiberene, with
ginger, to which it is related.Turmeric components have been
shown in animal studies to inhibit leukotriene biosynthesis and
to inhibit cyclo-oxygenase and arachidonic acid release; anti
platelet aggregation, and fibrinogenlowering properties have
also been demonstrated. It has been suggested (without adequate
evidence, however) that turmeric acts like a COX-2 inhibitor in
the treatment of arthritis. Curcumin and other turmeric
components, such as borneol, curcumene, and azulene, have been
shown in animal studies to have anti-inflammatory properties
and to have protective effects for hepatocytes against toxins,
hepatitis C virus, and HIV. Other hepatic benefits of turmeric
have been described, including inhibition of cytochrome P450
and glutathione 2-transferase; aflatoxin damage in ducklings
has been reversed by curcumin.
Curcumin
|
Clinical
Trials:Clinical trials
have been primarily published in local journals from Asian
countries. There have been no clinical studies on turmeric or
curcumin from Europe or North America.
Inflammation and Arthritis-In a
randomized, double-blind, crossover trial from India, of
6-month duration and conducted on 42 patients with
osteoarthrits, Articulin-F, an herbal mixture containing
turmeric (plus ashwagandha, frankincense, and zinc) improved
pain and disability scores compared to placebo. Although the
results were statistically significant, the individual effect
of turmeric was not evaluated and the dose of turmeric (300
mg/day) was relatively small. A "preliminary" double-blind RCT
on 18 patients with rheumatoid arthritis suggested curcumin 400
mg ti.d. was as effective as phenylbutazone 100 mg t.i.d.;
however, upon analyses of the results, phenylbutazone appeared
more effective, and there was no adequate placebo
control.
Other Indications-An open study
on patients with chronic anterior uveitis evaluated 53
patients, with 21 lost to follow-up. Eighteen patients with a
weak reaction to purified protein derivative (PPD) received
375 mg t.i.d. of turmeric alone for 12 weeks, versus 12
patients with a strong PPD reaction who received turmeric
combined with antitubercular drugs for 1 year. The 18 patients
receiving turmeric alone all improved within the initial 12
weeks, compared to 86% of the combined treatment group. After 3
years of follow-up, there was a higher recurrence rate in the
turmeric group (55%) than the combination treatment group
(36%), with similar rates of vision loss. The authors suggest
that turmeric may be beneficial in treating chronic anterior
uveitis, but the results of this non-blinded and poorly
controlled study are difficult to interpret
Small uncontrolled studies in
India and China have reported potential effects of turmeric or
curcumin in lowering serum cholesterol In an open study of 45
patients that assessed cholesterol as a secondary endpoint
over 4 weeks, triglycerides were reduced, but total cholesterol
was unaffected. An uncontrolled pilot study in India involving
814 patients reported that a paste of turmeric combined with
neem was beneficial to treat scabies.
Adverse
EffectsEncapsulated
turmeric or curcumin administered in the clinical trials was
well tolerated; side effects were qenerally similar to placebo.
In one trial of patients with duodenal ulcers, a burning
sensation was reported twice as often in Ihe turmeric group
than in the placebo group (13% and 7%, respectively). There are
rare cases of allergic contact dermatitis reported.
Side Effects and Interactions:
Turmeric has anti platelet effects in vitro, which could have
an additive effect with anticoagulants or antiplatelet drugs.
However, antiplatelet effects have not been demonstrated in
vivo, and no adverse effects or interactions have been reported
in the clinical trials or from individual cases.
Cautions:The safety of the herb (especially the
turmeric extract, curcumin) in pregnancy and during breast
feeding has not been determined. Its choleretic effect may, in
theory, cause an increase in symptoms in patients with
gallbladder or biliary disease, but this has not been reported
in humans, and the effect is unlikely.
Preparations &
Doses:Turmeric is used
in foods, and is readily available as powders or capsules.
Various extracts containing curcumin are available in liquid
form or in proprietary mixtures. In the clinical trials,
turmeric root or powder preparations were administered in a
dose of 1-6 g/day, typically divided three times daily, whereas
doses of about 400 mg t.i.d. of curcumin were used. Quality
turmeric products are allegedly standardized to contain not
less than 3% curcumin, and not less than 3% volatile oils. Much
larger amounts of curcumin can be administered than turmeric;
the usual dose of 1200 mg/day of curcumin is equal to about 40
g/day of turmeric (containing 3% curcumin). A heaping teaspoon
of powdered turmeric is about 4 g.
Summary
EvaluationTurmeric is
a valued spicy condiment that has been traditionally used to
improve digestion and to treat dyspepsia and inflammatory
disorders. Turmeric and its major component, curcumin, are also
promoted as antioxidants; cancer, HIV, and
hypercholesterolemia treatments; and cardiovascular disease
preventatives. However, controlled clinical trials are either
lacking for these indications or have not shown convincingly
positive results. A clinical benefit has not been demonstrated
for peptic ulcer disease, and one study was inconclusive for
dyspepsia. Controlled trials for arthritis and inflammation
also do not adequately demonstrate beneficial effects. Other
uses have not been evaluated in controlled clinical
trials.
By Dr John Anne
Read more about the benefits of
Triphala. Also find Herbal Colon Cleansing at
http://www.ayurvediccure.com
- World's Finest Portal on Ayurveda and Ayurvedic
Treatments
|
|
|
|